Our analysis showed that the expression of p21CIP1, H3K9Me3, and Lamin B1 in tumor samples of patients who developed partial or incomplete response to NAC was 94.6, 75.7, and 48.6%, respectively (Figure 1A). Here, CDKN1A is linked to neoplasm.